Evaluation and management of syphilis in the HIV-infected patient

被引：11

作者：

Ghanem K.G. ^{[1
]}

机构：

[1] Infectious Diseases Division, Johns Hopkins University, Bayview Medical Center, Baltimore, MD 21224, 4940 Eastern Avenue, B3N

来源：

Current Infectious Disease Reports | 2010年 / 12卷 / 2期

关键词：

Antiretroviral therapy; HAART; HIV; Neurosyphilis; Syphilis;

D O I：

10.1007/s11908-010-0083-6

中图分类号：

学科分类号：

摘要：

Rates of syphilis continue to increase in the United States and HIV-infected patients make up a large proportion of cases. The interaction between syphilis and HIV is complex and still incompletely understood. Although diagnosis and management of HIV-infected patients with syphilis is, in general, similar to HIV-uninfected patients, the former may be at increased risk for complications. Recent data suggest that HIV-induced immunosuppression may alter the course of syphilis and that highly active antiretroviral therapy may have a beneficial effect on syphilis outcomes. Prevention strategies consisting of sexual risk assessments, condom use, treatment of infected partners, yearly screening for syphilis of all HIV-infected patients, and enhanced clinical and serologic follow-up of treated HIV-infected patients are critical components of a comprehensive approach to care. © The Author(s) 2010.

引用

页码：140 / 146

页数：6

共 37 条

[1]

Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, (2007)

[2]

Fleming D.T., Wasserheit J.N., From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection, Sex Transm Infect, 75, pp. 3-17, (1999)

[3]

Buchacz K., Patel P., Taylor M., Et al., Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections, AIDS, 18, pp. 2075-2079, (2004)

[4]

Dowell D., Polgreen P.M., Beekmann S.E., Et al., Dilemmas in the management of syphilis: A survey of infectious diseases experts, Clin Infect Dis, 49, pp. 1526-1529, (2009)

[5]

Sparling P.F., Swartz M.N., Musher D.M., Healy B.P., Clinical manifestations of syphilis, Sexually Transmitted Diseases, pp. 661-684, (2008)

[6]

Rompalo A.M., Joesoef M.R., O'Donnell J.A., Et al., Clinical manifestations of early syphilis by HIV status and gender: Results of the syphilis and HIV study, Sex Transm Dis, 28, pp. 158-165, (2001)

[7]

Flood J.M., Weinstock H.S., Guroy M.E., Et al., Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992, J Infect Dis, 177, pp. 931-940, (1998)

[8]

Centers for disease control and prevention (CDC): Symptomatic early neurosyphilis among hiv-positive men who have sex with men-four cities, United States, January 2002-June 2004, MMWR Morb Mortal Wkly Rep, 56, pp. 625-628, (2007)

[9]

Ghanem K.G., Moore R.D., Rompalo A.M., Erbelding E.J., Zenilman J.M., Gebo K.A., Neurosyphilis in a clinical cohort of HIV-1-infected patients, AIDS, 22, pp. 1145-1151, (2008)

[10]

Musher D.M., Syphilis, neurosyphilis, penicillin, and AIDS, J Infect Dis, 163, pp. 1201-1206, (1991)

← 1 2 3 4 →